Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Long-term follow-up of patients who received repeat-dose rituximab as maintenance therapy for ANCA-associated vasculitis
Authors
Keywords
-
Journal
RHEUMATOLOGY
Volume 54, Issue 7, Pages 1153-1160
Publisher
Oxford University Press (OUP)
Online
2014-12-05
DOI
10.1093/rheumatology/keu452
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Long-Term Maintenance Therapy Using Rituximab-Induced Continuous B-Cell Depletion in Patients with ANCA Vasculitis
- (2014) W. F. Pendergraft et al. Clinical Journal of the American Society of Nephrology
- Damage in the anca-associated vasculitides: long-term data from the European Vasculitis Study group (EUVAS) therapeutic trials
- (2013) Joanna Robson et al. ANNALS OF THE RHEUMATIC DISEASES
- Decreased CD5+ B Cells in Active ANCA Vasculitis and Relapse after Rituximab
- (2013) D. O. Bunch et al. Clinical Journal of the American Society of Nephrology
- Impact of rituximab trials on the treatment of ANCA-associated vasculitis
- (2013) F. Alberici et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Efficacy of Remission-Induction Regimens for ANCA-Associated Vasculitis
- (2013) Ulrich Specks et al. NEW ENGLAND JOURNAL OF MEDICINE
- Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis
- (2012) Alfred Mahr et al. ANNALS OF THE RHEUMATIC DISEASES
- Fcγ receptor type IIIA polymorphism influences treatment outcomes in patients with rheumatoid arthritis treated with rituximab
- (2012) A Ruyssen-Witrand et al. ANNALS OF THE RHEUMATIC DISEASES
- Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): Ten-year experience at a single center
- (2012) Rodrigo Cartin-Ceba et al. ARTHRITIS AND RHEUMATISM
- Rituximab for remission maintenance in relapsing antineutrophil cytoplasmic antibody-associated vasculitis
- (2012) Rona M. Smith et al. ARTHRITIS AND RHEUMATISM
- Association Between −174 Interleukin-6 Gene Polymorphism and Biological Response to Rituximab in Several Systemic Autoimmune Diseases
- (2012) Gema Robledo et al. DNA AND CELL BIOLOGY
- Genetically Distinct Subsets within ANCA-Associated Vasculitis
- (2012) Paul A. Lyons et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risk factors for relapse of antineutrophil cytoplasmic antibody-associated vasculitis
- (2011) Michael Walsh et al. ARTHRITIS AND RHEUMATISM
- A Plasmablast Biomarker for Nonresponse to Antibody Therapy to CD20 in Rheumatoid Arthritis
- (2011) K. Owczarczyk et al. Science Translational Medicine
- Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
- (2010) John H. Stone et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
- (2010) Rachel B. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deoxyspergualin in relapsing and refractory Wegener's granulomatosis
- (2008) O Flossmann et al. ANNALS OF THE RHEUMATIC DISEASES
- EULAR recommendations for the management of primary small and medium vessel vasculitis
- (2008) C Mukhtyar et al. ANNALS OF THE RHEUMATIC DISEASES
- Relapsed Wegener's granulomatosis after rituximab therapy--B cells are present in new pathological lesions despite persistent 'depletion' of peripheral blood
- (2008) A. J. Ferraro et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Azathioprine or Methotrexate Maintenance for ANCA-Associated Vasculitis
- (2008) Christian Pagnoux et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More